Join

or

Existing user? Login

News: BNF correction

Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7166 p373-376
22 September 2001

This article
Reprint
Photocopy


News summary


BNF correction

The section on bisphosphonates in the latest edition of the British National Formulary (no. 42) contains a misleading statement in its discussion of disodium etidronate.

It states that disodium etidronate can impair bone mineralisation (section 6.6.2, p364). Although this is true when giving the drug continously to treat Paget’s disease, the text does not say that it is of little relevance when the drug is used intermittently for the treatment and prevention of osteoporosis.

The electronic versions of the BNF have been corrected and the text will be reworded for the next edition of the book.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©Electronicjuice

Citation: Electronicjuice URI: 20005031

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Electronicjuice, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

roof repairs Providence

roofing costs Providence

cialis-viagra.com.ua